Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Callion Pharma is a specialty pharmaceutical and nutritional science company focused on developing advanced delivery technologies for patients with malabsorption disorders. The company specializes in the formulation of fat-soluble vitamins (A, D, E, and K) using proprietary delivery platforms that enhance absorption in individuals with conditions such as cystic fibrosis, bariatric surgery, and cholestatic liver diseases. Its flagship product line, DEKAs, provides specialized micronutrient support in various formats including capsules, chewable tablets, and liquid drops. Headquartered in Tennessee, Callion Pharma serves a global market, providing medical foods and dietary supplements designed to meet rigorous clinical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Callion Pharma.